Tissue Regenix Expects Annual Revenue Rise After Demand Surge

Mon, 04th Feb 2019 11:37

LONDON (Alliance News) - Tissue Regenix Group PLC said Monday it expects annual revenue to rise by 47% on the back of strong customer demand across all its brands.

For 2018, the company said it expects revenue of GBP11.6 million, up from GBP7.9 million a year ago.

DermaPure revenue grew 79% on a constant currency basis to GBP3.4 million, and Orthopaedics & Dental revenue grew by 31% to GBP6.4 million, while the firm's joint venture GBM-v delivered sales of GBP1.8 million.

Tissue Regenix shares were trading up 5.4% at 6.06 pence each.

Related Shares

More News

18 Apr 2024 14:12

UK shareholder meetings calendar - next 7 days

19 Mar 2024 14:24

Tissue Regenix annual loss narrows sharply as revenue jumps

(Alliance News) - Tissue Regenix Group PLC on Tuesday said it was aiming for longer-term growth as it reported a sharp reduction in its annual losses.

12 Mar 2024 14:29

UK earnings, trading statements calendar - next 7 days

6 Feb 2024 10:42

IN BRIEF: Tissue Regenix ships first allograft products order

Tissue Regenix Group PLC - Leeds, England-based medical devices - First order of its allograft products has been shipped from its third-party Irish lo...

25 Jan 2024 20:21

TRADING UPDATES: Treatt revenue falls; Secure Trust profit picks up

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: